Regulatory functions of phospholipase A2

Critical Reviews in Immunology

Volumn 17, Issue 3-4, 1997, Pages 225-283

  Murakami, Makoto ^a   Nakatani, Yoshihito ^a   Atsumi, Gen Ichi ^a   Inoue, Keizo ^b   Kudo, Ichiro ^a  

^a SHOWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Ca2+ independent phospholipase A2; Cyclooxygenase; Cytosolic phospholipase A2; Leukotriene; Prostaglandin; Secretory phospholipase A2

Indexed keywords

ARACHIDONIC ACID; FATTY ACID; LEUKOTRIENE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; THROMBOCYTE ACTIVATING FACTOR;

ACUTE PANCREATITIS; CELL ADHESION; CELL FUNCTION; DEGRANULATION; ENZYME REGULATION; ENZYME RELEASE; ENZYME STRUCTURE; FAT INTAKE; IMMUNE RESPONSE; LIPID METABOLISM; MEDIATOR RELEASE; PRIORITY JOURNAL; REVIEW; STEM CELL; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA; PHOSPHOLIPASES A;

EID: 0030921327     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (439)

1. 2, J. Biol. Chem., 269, 13057, 1994.
2. 2, Biochim. Biophys. Acta, 1170, 217, 1993.
3. 2, J. Lipid Med. Cell Sig., 12, 119, 1995.
4. 2s; comparison of arachidonoyl-selective and -nonselective enzymes, FASEB J., 7, 339, 1993.
5. 2 - a mediator between proximal and distal effectors of inflammation, Immunol. Today, 12, 143, 1991.
6. 2, J. Lipid Med. Cell Sig., 12, 83, 1995.
7. 2, Biochim. Biophys. Acta, 1259, 125, 1995.
8. Bazan, N. G., A signal terminator, Nature, 374, 501, 1995.
9. 2 based on structural determinants, J. Biol. Chem., 252, 4913, 1977.
10. 2, Rev. Physiol. Biochem. Pharmacol., 91, 92, 1981.
11. Waite, M., The Phospholipases, Plenum Press, New York, 1987.
12. de Haas, G. H., Postema, N. M., Nieuwenhuizen, W., and van Deenen, L. L. M., Purification and properties of phospholipase A from porcine pancreas, Biochim. Biophys. Acta, 159, 103, 1968.
13. 2, J. Biol. Chem., 264, 5768, 1989.
14. 2 present in rheumatoid arthritic synovial fluid, J. Biol. Chem., 264, 5335, 1989.
15. 2, J. Biochem. (Tokyo), 106, 545, 1989.
16. 2, Biochem. Biophys. Res. Commun., 162, 1030, 1989.
17. 2, J. Biol. Chem., 269, 2365, 1994.
18. 2s containing 16 cysteines, J. Biol. Chem., 269, 23018, 1994.
19. 2: isolation of the human gene and cDNAs from porcine pancreas and human lung, DNA, 5, 519, 1986.
20. 2, Biochem. Biophys. Res. Commun., 168, 1059, 1990.
21. 2 at 2.2 A resolution, Nature, 352, 79, 1991.
22. 2 from inflammatory exudate, Science, 254, 1007, 1991.
23. 2 from peritoneal cavity of caseinate-treated rat, J. Biochem. (Tokyo), 102, 147, 1987.
24. 2 released from rat platelets, J. Biochem. (Tokyo), 101, 625, 1987.
25. 2 and its characteristics, J. Biochem. (Tokyo), 105, 520, 1989.
26. 2 from human synovial fluid in rheumatoid arthritis, J. Biochem. (Tokyo), 105, 395, 1989.
27. 2 S-1, J. Biol. Chem., 263, 5732, 1988.
28. 2 in pancreatic beta cells reguration of mRNA levels by starvation or glucose excess, FEBS Lett., 295, 110, 1991.
29. Hatao, M., On etiology and pathophysiology of acute pancreatitis: with special reference to participation of phospholipase A, Arch. Jpn. Chir., 38, 76, 1969.
30. Schmidt, H. and Creutzfeldt, W., The possible role of phospholipase A in the pathogenesis of acute pancreatitis, Scand. J. Gastroenterol., 4, 39, 1969.
31. Wanke, M., Experimental acute pancreatitis, Curr. Top. Pathol., 52, 64, 1970.
32. Rimin, A. and Shapiro, B., Properties and specificity of pancreatic phospholipase A, Biochem. J., 71, 620, 1959.
33. Beger, H. G., Buchler, M., Bittner, R., Oettinger, W., Block, S., and Nevalainen, T., Necrosectomy and postoperative local lavage in patients with necrotizing pancreatitis: results of a prospective clinical trial, World J. Surg., 12, 255, 1988.
34. 2 on peritoneal permeability changes in acute experimental pancreatitis, Int. J. Pancreatol., 6, 71, 1990.
35. Aho, H. J., Koskensalo, S. M.-L., and Nevalainen, T. J., Experimental pancreatitis in the rat: sodium taurocholate-induced acute hemorrhagic pancreatitis, Scand. J. Gastroenterol., 15, 411, 1980.
36. Nevalainen, T. J., The role of phospholipase A in acute pancreatitis, Scand. J. Gastroenterol., 15, 641, 1980.
37. 2 in Clinical Inflammation: Molecular Approaches to Pathophysiology, Glacer K. B. and Vadas, P., Eds., CRC Press, Boca Raton, 1995, 149.
38. 2 in sodium taurocholate-induced experimental hemorrhagic pancreatitis in the rat, J. Surg. Res., 59, 271, 1995.
39. 2, Toxicon, 27, 613, 1989.
40. Hawgood, B. and Bon, C., Reptile venoms and toxins, in Handbook of Natural Toxins, Tu, A. T., Ed., Marcel Dekker, New York, 1991, 3.
41. 2 enzymes, Eur. J. Pharmacol., 190, 347, 1990.
42. 2, Am. J. Pathol., 134, 807, 1989.
43. Lambeau, G., Barhanin, J., Schweitz, H., Qar, J., and Lazdunski, M., Identification and properties of very-high-affinity brain membrane-binding sites for a neurotoxic phospholipase from the taipan venom, J. Biol. Chem., 264, 11503, 1989.
44. 2 in skeletal muscle, J. Biol. Chem., 265, 9526, 1990.
45. 2, J. Biol. Chem., 263, 5724, 1988.
46. 2 from rat stomach, Biochim. Biophys. Acta, 1046, 189, 1990.
47. 2 isoforms in rat kidney: their role in eicosanoid synthesis, Biochim. Biophys. Acta, 1257, 11, 1995.
48. 2 in Swiss 3T3 cells via specific binding site, J. Biol. Chem., 266, 19139, 1991.
49. 2 on isolated porcine cerebral arteries via its specific binding sites, FEBS Lett., 309, 261, 1992.
50. 2 via specific binding sites, Biochim. Biophys. Acta, 1125, 210, 1992.
51. 2 stimulates prostaglandin synthesis in mouse osteoblastic cells (MC3T3-E1) via a specific binding site, J. Biol. Chem., 268, 2865, 1993.
52. 2 in the rat: its cellular and tissue distribution, J. Biol. Chem., 267, 6414, 1992.
53. 2, Biochim. Biophys. Acta, 1127, 233, 1992.
54. 2 to its specific receptor, Biochem. Biophys. Res. Commun., 209, 293, 1995.
55. 2 receptor, J. Biol. Chem., 269, 5897, 1994.
56. 2, J. Biol. Chem., 269, 1575, 1994.
57. 2: molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization, J. Biol. Chem., 270, 8963, 1995.
58. Ezekowitz, R. A. B., Sastry, K., Bailly, P., and Warner, A., Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells, J. Exp. Med., 172, 1785, 1990.
59. Taylor, M. E., Conary, J. T., Lennartz, M. R., Stahl, P. D., and Drickamer, K., Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains, J. Biol. Chem., 265, 12156, 1990.
60. 2 receptors from various mammals, Eur. J. Biochem., 225, 375, 1994.
61. 2 on their M-type 180-kDa membrane receptor, J. Biol. Chem., 270, 28869, 1995.
62. 2 involved in the binding to M-type receptors, J. Biol. Chem., 270, 5534, 1995.
63. 2, J. Biol. Chem., 271, 250, 1996.
64. 2 expression and prostaglandin biosynthesis in rat mesangial cells, J. Biol. Chem., 269, 5092, 1994.
65. 2s on brain synaptic membranes, Biochemistry, 30, 11473, 1991.
66. 2 by site-directed mutagenesis, J. Biol. Chem., 270, 2120, 1995.
67. 2, J. Biol. Chem., 264, 10008, 1989.
68. 2 from human ileal mucosa, Biochim. Biophys. Acta, 1170, 125, 1993.
69. 2, J. Biochem. (Tokyo), 104, 767, 1988.
70. 2: purification and some molecular characteristics, Biochemistry, 21, 6883, 1982.
71. 2 purified from an inflammatory exudate, Biochemistry, 25, 8381, 1986.
72. 2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate, J. Biol. Chem., 265, 6675, 1990.
73. 2 from human spleen, Biochem. Biophys. Res. Commun., 163, 42, 1989.
74. 2 in human seminal plasma, Biochem. Biophys. Res. Commun., 178, 1505, 1991.
75. 2, Adv. Exp. Med. Biol., 279, 173, 1990.
76. 2 added exogenously, J. Biochem. (Tokyo), 110, 163, 1991.
77. 2, FEBS Lett., 294, 247, 1991.
78. 2, J. Biol. Chem., 268, 839, 1993.
79. 2 as a result of interfacial activation by specific anions, Biochem. J., 308, 507, 1995.
80. 2 in human polymorphonuclear leukocytes, Biochim. Biophys. Acta, 879, 149, 1986.
81. 2 in rat zymosan-induced pleurisy, J. Biochem. (Tokyo), 114, 509, 1993.
82. 2 in granules and secrete active enzyme in response to soluble stimuli, Biochem. Biophys. Res. Commun., 208, 650, 1995.
83. 2 which preferentially hydrolyzed an arachidonoyl residue, J. Biochem. (Tokyo), 108, 903, 1990.
84. 2 from rat platelets, J. Biochem. (Tokyo), 103, 263, 1988.
85. 2 in cultured mast cells, J. Biochem. (Tokyo), 111, 175, 1992.
86. 2, J. Biochem. (Tokyo), 104, 884, 1988.
87. 2 from Bothrops asper snake venom: identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling, J. Biol. Chem., 269, 29867, 1994.
88. 2 by heparin, Eur. J. Biochem., 221, 481, 1994.
89. 2 and lysophosphatidylserine-specific lysophospholipase from rat platelets, J. Biochem. (Tokyo), 101, 53, 1987.
90. 2 activity in platelets: immuno-purification and localization of the enzyme in rat platelets, J. Lipid Med., 1, 49, 1989.
91. 2, Biochim. Biophys. Acta, 1005, 270, 1989.
92. 2 from rat liver, Biochim. Biophys. Acta, 1169, 1, 1993.
93. 2 in the rat, Biochim. Biophys. Acta, 1043, 34, 1990.
94. 2, on human neutrophil function, Biochem. Pharmacol., 47, 1661, 1994.
95. 1 cells, J. Biol. Chem., 268, 21875, 1993.
96. 2 by guinea pig alveolar macrophages: dissociation from arachidonic acid liberation and modulation by dexamethasone, J. Immunol., 151, 5613, 1993.
97. 2 in the secretory granule, Biochem. J., 300, 619, 1994.
98. 2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells, J. Immunol., 152, 5438, 1994.
99. 2 and distal prostaglandin synthase 1, J. Biol. Chem., 271, 186, 1996.
100. 2 from activated mast cells and its possible involvement in the regulation of the degranulation process, Eur. J. Biochem., 209, 257, 1992.
101. 2 in rat paneth cells, Histochemistry, 81, 581, 1984.
102. 2 in mononuclear phagocytic cells in rat spleen and liver, Eur. J. Biochem., 197, 323, 1991.
103. 2 is an endotoxin-stimulated membrane-associated enzyme of Kupffer cells which is released during liver perfusion, Biochem. J., 293, 143, 1993.
104. 2, FEBS Lett., 268, 113, 1990.
105. 2 purified from rheumatoid synovial fluid, J. Biochem. (Tokyo), 104, 326, 1988.
106. 2 activity in peritoneal cavity of casein-treated rats, J. Biochem. (Tokyo), 100, 1099, 1986.
107. 2 in pleural effusion of patients with tuberculosis, Life Sci., 49, 1095, 1991.
108. 2 detected at inflamed sites in rats does not originate from platelets, Agents Actions, 32, 266, 1991.
109. 2 by lipopolysaccharide in the liver of BCG-primed rat, Biochem. Biophys. Res. Commun., 174, 1077, 1991.
110. 2 in alveolar macrophages: down-regulation by an inflammatory signal, J. Biol. Chem., 270, 17327, 1995.
111. Mulherkar, R., Rao, R. S., Wagle, A. S., Patki, V., and Deo, M. G., Enhancing factor, a Paneth cell-specific protein from mouse small intestines: predicted amino acid sequence from RT-PCR-amplified cDNA and its expression, Biochem. Biophys. Res. Commun., 195, 1254, 1993.
112. Min-induced intestinal neoplasia, Cell, 81, 957, 1995.
113. 2 gene in inbred mouse strains, J. Biol. Chem., 270, 22378, 1995.
114. 2 gene alterations in human colorectal cancer, Cancer Res., 55, 5184, 1995.
115. 2 gene expression in human hepatoma cells by mediators of the acute phase response, J. Biol. Chem., 266, 2647, 1991.
116. 2 by unstimulated human articular chondrocytes, J. Rheumatol., 17, 1386, 1990.
117. 2, J. Rheumatol., 17, 1392, 1990.
118. 2 mRNA synthesis in rabbit articular chondrocytes, Biochem. Biophys. Res. Commun., 164, 488, 1989.
119. 2 mRNA levels, and eicosanoid formation in rabbit chondrocytes, Biochem. Biophys. Res. Commun., 165, 1079, 1989.
120. 2, Exp. Cell Res., 206, 58, 1993.
121. 2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells, FEBS Lett., 261, 171, 1990.
122. 2 production by blocking mRNA synthesis and posttranscriptional expression, J. Biol. Chem., 265, 12745, 1990.
123. 2 in rat vascular smooth muscle cells and its possible relationship to eicosanoid formation, Biochim. Biophys. Acta, 1082, 285, 1991.
124. 2 and cyclooxygenase-2 expression by tracheobronchial smooth muscle cells, Eur. J. Biochem., 235, 557, 1996.
125. 2 secreted and anchored on cell-surface heparan sulfate proteoglycan, Eur. J. Biochem., 218, 807, 1993.
126. 2 in rat cultured astrocytes: two distinct pathways of the gene expression, J. Biol. Chem., 266, 9956, 1991.
127. 2, J. Biol. Chem., 266, 14119, 1991.
128. 2 in rat mesangial cells, Biochem. Biophys. Res. Commun., 174, 268, 1991.
129. 2 in rat mesangial cells is prevented by dexamethasone, Biochem. Biophys. Res. Commun., 180, 46, 1991.
130. 2, J. Biol. Chem., 267, 8846, 1992.
131. 2 gene expression by interleukin-1 and forskolin in rat mesangial cells, FEBS Lett., 301, 190, 1992.
132. 2 gene expression by interleukin 1 and forskolin in mesangial cells, FEBS Lett., 291, 249, 1991.
133. 2 by rat mesangial cells: its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomeruler cells, J. Clin. Invest., 2516, 1993.
134. 2 expression in rat mesangial cells, J. Clin. Invest., 2524, 1993.
135. 2 by brefeldin A, FEBS Lett., 332, 99, 1993.
136. 2 in rat renal mesangial cells, FEBS Lett., 364, 218, 1995.
137. 2 activates mitogen-activated protein kinase in cultured rat mesangial cells, FEBS Lett., 370, 141, 1995.
138. 2 secretion is a common effector pathway of interleukin-1 and tumor necrosis factor action, Immunol. Lett., 28, 187, 1991.
139. 2 from fetal rat calvarial cells in vitro: relationship to bone nodule formation, J. Bone Mineral Res., 6, 843, 1991.
140. 2 by cytokines inhibiting bone formation and mineralization, Biochem. Biophys. Res. Commun., 188, 1047, 1992.
141. 2 in human synovial cells, Arthritis Rheumatism, 31, 126, 1988.
142. 2 induced by interleukin-1β in cultured rat gingival fibroblasts, FEBS Lett., 304, 69, 1992.
143. 2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid, FEBS Lett., 273, 23, 1990.
144. 2 in invasive gastric cancer cell line is induced by interleukin 6, Biochem. Biophys. Res. Commun., 198, 878, 1994.
145. Otto, J. C. and Smith, W. L., Prostaglandin endoperoxidase-1 and -2, J. Lipid Med. Cell. Sig., 12, 139, 1995.
146. Kujubu, D. A. and Herschman, H. R., Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene, J. Biol. Chem., 267, 7991, 1992.
147. DeWitt, D. L. and Meade, E. A., Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes, Arch. Biochem. Biophys., 306, 94, 1993.
148. Mitchell, J. A., Larkin, S., and Williams, T. J., Cyclooxygenase-2: regulation and relevence in inflammation, Biochem. Pharmacol., 50, 1535, 1995.
149. 2(s) by transforming growth factor-β, Biochim. Biophys. Acta, 1256, 201, 1995.
150. 2 expression and arachidonic acid release by rabbit articular chondrocytes, FEBS Lett., 340, 51, 1994.
151. 2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis, Gut, 33, 914, 1992.
152. 2 protein in sera of patients with Crohn's disease and ulcerative colitis, Am. J. Gastroenterology, 88, 1076, 1993.
153. 2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis, Gut, 35, 1593, 1994.
154. 2 in the pathobiology of disease, Lab. Invest., 55, 391, 1986.
155. 2 and its role in the pathogenesis of inflammation in arthritis, J. Rheumatol., 15, 1601, 1988.
156. 2 in rabbits, J. Invest. Dermatol., 86, 380, 1986.
157. 2 induces a synovitis-like inflammation in the rat air pouch, J. Rheumatol., 32, 824, 1994.
158. 2: structural and functional changes, Am. Rev. Resp. Dis., 143, 1102, 1991.
159. 2 induces an inflammatory response in rabbit joints, J. Immunol., 146, 3904, 1991.
160. 2 purified from human synovial fluid and inhibition by aristolochic acid, Inflammation, 12, 549, 1988.
161. 2 in the inflammatory process of carrageenan-induced pleurisy in rats, FEBS Lett., 339, 76, 1994.
162. 2 inhibitor, thielocin A1β, and mechanism of action, J. Antibiotics, 45, 1071, 1992.
163. 2-specific inhibitor from ascomycetes, J. Antibiotics, 47, 631, 1994.
164. 2 inhibitors produced by Thielavia terricola RF-143, J. Antibiotics, 48, 106, 1995.
165. 2-specific inhibitor, in rat carrageenan-induced pleurisy, Inflammation, 17, 107, 1993.
166. 2 by the marine natural product, manoalide, Biochem. Pharmacol., 39, 1557, 1990.
167. Bennett, C. F., Mong, S., Wu, H.-L. W., Clark, M. A., Wheeler, L., and Crooke, S. T., Inhibition of phosphoinositide-specific phospholipase C by manoalide, Mol. Pharmacol., 32, 587, 1987.
168. De Vries, G. W., Amdahl, L., Mobasser, A., Wenzel, M., and Wheeler, L. A., Preferential inhibition of 5-lipoxygenase activity by manoalide, Biochem. Pharmacol., 37, 2899, 1988.
169. Wheeler, L. A., Sachs, G., De Vries, G., Goodrum, D., Woldemussie, E., and Muallem, S., Manoalide, a natural sesterterpenoid that inhibits calcium channels, J. Biol. Chem., 262, 6531, 1987.
170. 2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation, J. Pharmacol. Exp. Ther., 268, 709, 1994.
171. 2, J. Pharmacol. Exp. Ther., 263, 1302, 1992.
172. 2, Br. J. Pharmacol., 110, 447, 1993.
173. 2 inhibitors, Eur. J. Med. Chem., 26, 667, 1991.
174. 2 inhibition by alkylbenzoylacrylic acids, Biochem. Pharmacol., 44, 805, 1992.
175. 2), Agents Actions, 39, C30, 1993.
176. 2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock, J. Pharmacol. Exp. Ther., 274, 1254, 1995.
177. 2-dependent release of fatty acids from peroxide membrane, J. Free Radicals Biol. Med., 1, 263, 1985.
178. 2 in mitochondria enriched with n-3 fatty acids, Proc. Natl. Acad. Sci. U.S.A., 87, 8845, 1990.
179. Chiariello, M., Ambrosio, G., Cappelli-Bigazzi, M., Nevola, E., Perrone-Filardi, P., Marone, G., and Condorelli, M., Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion, J. Pharmacol. Exp. Ther., 241, 560, 1987.
180. 2 enzymatic acitivity after renal ischemia and reperfusion, J. Clin. Invest., 87, 1810, 1991.
181. 2) activity in gerbil brain: enhanced activities of cytosolic, mitochondrial, and microsomal forms after ischemia and reperfusion, J. Neurosci., 11, 1829, 1991.
182. 2 in rat brain after severe forebrain ischemia and in endotoxin shock, Brain Res., 651, 353, 1994.
183. Kikuchi-Yanoshita, R., Yanoshita, R., Kudo, I., Arai, H., Takamura, T., Nomoto, K., and Inoue, K., Preferential hydrolysis of phosphatidylethanolamine in rat ischemic heart homogenates during in vitro incubation, J. Biochem. (Tokyo), 114, 33, 1993.
184. Arai, H., Cell damage and phospholipid metabolism in drug-induced oxidative injury, Protein Nucl. Acid Enzyme, 36, 453, 1991.
185. 2 mediates neutrophil priming and lung injury after mesenteric ischemia-reperfusion, Am. J. Physiol., 268, G397, 1995.
186. Reddy, S. T. and Herschman, H. R., Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages, J. Biol. Chem., 269, 15473, 1994.
187. 2 in mouse bone marrow-derived mast cells, J. Biol. Chem., 269, 22269, 1994.
188. Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., and Smithies, O., Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse, Cell, 83, 473, 1995.
189. Inoue, H., Yokoyama, C., Hara, S., Tone, Y., and Tanabe, T., Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells: involvement of both nuclear factor for interleukin-6 expression and cAMP response element, J. Biol. Chem., 270, 24965, 1995.
190. Yamamoto, K., Arakawa, T., Ueda, N., and Yamamoto, S., Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells, J. Biol. Chem., 270, 31315, 1995.
191. 2 enzymes, Proc. Natl. Acad. Sci. U.S.A., 91, 11060, 1994.
192. 2, Biochim. Biophys. Acta, 1300, 197, 1996.
193. 2 recombinant overexpression enhances stimulated arachidonic acid release, Biochem. Biophys. Res. Commun., 178, 1298, 1991.
194. 2 stimulates prostaglandin synthesis in rat liver-derived BRL-3A cells in the presence of tumor necrosis factor α, J. Biochem. (Tokyo), 118, 939, 1995.
195. 2 inhibit release of free arachidonate in thrombin-stimulated human platelets, J. Biol. Chem., 269, 15625, 1994.
196. 2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets, J. Biol. Chem., 269, 15619, 1994.
197. 2 is not required for arachidonic acid liberation during platelet activation, Eur. J. Biochem., 216, 169, 1993.
198. 2, J. Biol. Chem., 269, 3117, 1994.
199. 2, J. Clin. Invest., 93, 1583, 1994.
200. 2 translocates to membrane fraction in human neutrophils activated by stimuli that phosphorylate mitogen-activated protein kinase, Proc. Natl. Acad. Sci. U.S.A., 91, 3142, 1994.
201. 2, Biochem. J., 308, 815, 1995.
202. 2 in human neutrophils stimulated with tumor necrosis factor-α, Biochem. Biophys. Res. Commun., 209, 271, 1995.
203. 2 in human neutrophils, Biochem. J., 313, 503, 1996.
204. 2 in permealized human neutrophils, Biochim. Biophys. Acta, 1299, 223, 1996.
205. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells, Cell, 80, 919, 1995.
206. Yokoyama, K., Kudo, I., and Inoue, K., Phospholipid degradation in rat calcium ionophore-activated platelets is catalyzed mainly by two discrete secretory phospholipase As, J. Biochem. (Tokyo), 117, 1280, 1995.
207. Heller, R. A., and Krönke, M., Tumor necrosis factor receptor-mediated signaling pathways, J. Cell Biol., 126, 5, 1994.
208. Kolesnick, R. and Golde, D. W., The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling, Cell, 77, 325, 1994.
209. Elsbach, P. and Weiss, J., Phagocytosis of bacteria and phospholipid degradation, Biochim. Biophys. Acta, 947, 29, 1988.
210. Wright, G. C., Weiss, J., Kim, K. S., Verheij, H., and Elsbach, P., Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils: role of cellular and extracellular phospholipases, J. Clin. Invest., 85, 1925, 1990.
211. 2-independent bactericidal system, J. Clin. Invest., 69, 959, 1982.
212. Weiss, J., Kao, L., Victor, M., and Elsbach, P., Oxygen-independent intracellular and oxygen-dependent extracellular killing of Eschelichia coli S15 by human polymorphonuclear leukocytes, J. Clin. Invest., 76, 206, 1985.
213. Mannion, B. A., Weiss, J., and Elsbach, P., Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli, J. Clin. Invest., 86, 631, 1990.
214. 2 by protein engineering into enzyme active against Escherichia coli treated with the bactericidal/permeability-increasing protein, J. Biol. Chem., 266, 4162, 1991.
215. 2 in concert with polymorphonuclear leukocytes, J. Biol. Chem., 269, 26331, 1994.
216. 2, J. Clin. Invest., 95, 603, 1995.
217. 2, J. Biol. Chem., 262, 14402, 1987.
218. 2 on cell-free prothrombinase complex, J. Biol. Chem., 269, 26338, 1994.
219. 2+ ionophore A23187-induced release of histamine from rat basophilic leukemia cells, Arch. Biochem. Biophys., 212, 572, 1981.
220. 2, Science, 216, 305, 1982.
221. Frye, R. A. and Holz, R. W., Arachidonic acid release and catecholamine secretion from digitonin-treated chromaffin cells: effects of micromolar calcium, phorbol ester, and protein alkylating agents, J. Neurochem., 44, 265, 1985.
222. 2 inhibitors suppressed lysophosphatidylserine-dependent degranulation of rat peritoneal mast cells, Biochem. Biophys. Res. Commun., 181, 714, 1991.
223. Karli, U. O., Schäfer, T., and Burger, M. M., Fusion of neurotransmitter vesicles with target membrane is calcium independent in a cell-free system, Proc. Natl. Acad. Sci. U.S.A., 87, 5912, 1990.
224. 2, J. Immunol., 151, 5675, 1993.
225. 2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion, Biochem. J., 318, 701, 1996.
226. 2, J. Immunol., 151, 5639, 1993.
227. Lefkowith, J. B., Rogers, M., Lennartz, M. R., and Brown, E. J., Essential fatty acid deficiency impairs macrophage spreading and adherence, J. Biol. Chem., 266, 1071, 1991.
228. Lefkowith, J. B., Lennartz, M. R., Rogers, M., Morrison, A. R., and Brown, E. J., Phospholipase activation during monocyte adherence and spreading, J. Immunol., 149, 1729, 1992.
229. 2 reaction leads to increased monocyte adhesion of endothelial cells via the expression of adhesion molecules, Eur. J. Biochem., 217, 723, 1993.
230. ras by G protein-coupled receptor agonists in fibroblasts, Proc. Natl. Acad. Sci. U.S.A., 90, 1257, 1993.
231. raf-1, J. Biol. Chem., 268, 20717, 1993.
232. 2 activity in human neutrophils: stimulation by lipopolysaccharide and possible involvement in priming for an enhanced respiratory burst, J. Immunol., 151, 4918, 1993.
233. 2 in T-lymphocyte activation: implication in propagation of inflammatory reaction, Proc. Natl. Acad. Sci. U.S.A., 90, 716, 1993.
234. Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., and Dove, W. F., Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene, Science, 256, 668, 1992.
235. + in intestinal adenomas from Min mice, Cancer Res., 54, 5947, 1994.
236. Marnett, L. J., Aspirin and the potential role of prostaglandins in colon cancer, Cancer Res., 52, 5575, 1992.
237. Thun, M. J., Aspirin, NSAIDs and digestive tract cancers, Cancer Metastasis Rev., 13, 269, 1994.
238. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V., and Reddy, B. S., Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal antiinflammatory agent, Cancer Res., 55, 1464, 1995.
239. Tsujii, M. and DuBois, R. N., Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2, Cell, 83, 493, 1995.
240. 2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate, J. Clin. Invest., 97, 2233, 1996.
241. 2, Biochim. Biophys. Acta, 1215, 115, 1994.
242. 2 of human spermatozoa: purification and partial sequence, Biochem. Biophys. Res. Commun., 182, 208, 1992.
243. Blackwell, G. J., Carnuccio, R., Di Rosa, M., Flower, R. J., Parente, L., and Persico, P., Macrocortin: a polypeptide causing the antiphospholipase-like effects of glucocorticoids, Nature, 287, 147, 1980.
244. 2 by "lipocortins" and calpactins: an effect of binding to substrate phospholipids, J. Biol. Chem., 262, 1698, 1987.
245. Pepinsky, R. B., Tizard, K., Mattaliano, R. J., Sinclair, L. K., Miller, G. T., Browning, J. L., Chow, E. P., Burne, C., Huang, K.-S., Pratt, D., Watcher, L., Hession, C., Frey, A. Z., and Wallner, B. P., Five distinct calcium and phospholipid binding proteins share homology with lipocortin I, J. Biol. Chem., 263, 10799, 1988.
246. Errasfa, M. and Russo-Marie, F., A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice, Br. J. Pharmacol., 97, 1051, 1989.
247. Flower, R. J. and Rothwell, N. J., Lipocortin-1: cellular mechanisms and clinical relevance, Trends Pharmacol. Sci., 15, 71, 1994.
248. 2 purified from inflammatory sites in rats, Proc. Natl. Acad. Sci. U.S.A., 87, 2395, 1990.
249. 2 stimulatory peptide melittin, J. Biol. Chem., 262, 4402, 1987.
250. 2-activating protein, Proc. Natl. Acad. Sci. U.S.A., 88, 5418, 1991.
251. 2-activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflamamtory response in joints injected in vivo, J. Lab. Clin. Med., 116, 814, 1990.
252. 2-activating protein, J. Immunol., 145, 3391, 1990.
253. 2-activating protein, and release of linoleic acid from the murine T helper cell line EL-4, J. Immunol., 148, 155, 1992.
254. 2-activating protein induces the synthesis of IL-1 and TNF in human monocytes, J. Immunol., 154, 4027, 1995.
255. 2-activating protein (PLAP) stimulates human neutrophil aggregation and release of lysosomal enzymes, superoxide and eicosanoids, J. Immunol., 142, 3957, 1989.
256. 2-activating protein (PLAP) and melittin, Biochim. Biophys. Acta, 1166, 124, 1993.
257. 2-activating protein and the G protein β-subunits: a new concept of effector protein activation in signal transduction? Trends Biochem. Sci., 18, 292, 1993.
258. 2, Biochem. J., 309, 461, 1995.
259. Takamura, H., Narita, H., Park, H. J., Tanaka, K., Matsuura, T., and Kito, M., Differential hydrolysis of phospholipid molecular species during activation of human platelets with thrombin and collagen, J. Biol. Chem., 262, 2262, 1987.
260. Alonso, F., Henson, P. M., and Leslie, C. C., A cytosolic phospholipase in human neutrophils that hydrolyzes arachidonoyl-containing phosphatidylcholine, Biochim. Biophys. Acta, 878, 273, 1986.
261. 2 activity which preferentially hydrolyzes an arachidonoyl residue, J. Biochem. (Tokyo), 104, 492, 1988.
262. 2, Biochim. Biophys. Acta, 1083, 80, 1991.
263. 2 that preferentially hydrolyzes an arachidonoyl residue, FEBS Lett., 282, 326, 1991.
264. 2, J. Biochem. (Tokyo), 111, 54, 1992.
265. 2 from bovine platelets, Biochem. Biophys. Res. Commun., 174, 189, 1991.
266. 2-hydrolyzing arachidonoyl-phospholipids in mouse peritoneal macrophages, FEBS Lett., 244, 51, 1989.
267. 2 in mouse spleen and the macrophage cell line J774, Eur. J. Biochem., 202, 873, 1991.
268. 2 from the human monocytic cell line U937, Proc. Natl. Acad. Sci, U.S.A., 87, 7708, 1990.
269. 2 is a 100-kDa protein in human monoblast U937 cells, J. Biol. Chem., 266, 5268, 1991.
270. 2 from human monocytic leukemic U937 cells: calcium-dependent activation and membrane association, J. Biol. Chem., 265, 14654, 1990.
271. 2 from a macrophage cell line, RAW 264.7, Biochim. Biophys. Acta, 963, 476, 1988.
272. 2 in rat renal mesangial cells, J. Biol. Chem., 263, 16645, 1988.
273. 2 from rat kidney activated at physiological calcium concnetrations, Biochem. J., 271, 37, 1990.
274. 2 activity, Biochem. J., 294, 261, 1993.
275. 2+-dependent translocation domain with homology to PKC and GAP, Cell, 65, 1043, 1991.
276. 2, J. Biol. Chem., 266, 14850, 1991.
277. 2+-independent catalytic domain, J. Biol. Chem., 269, 18239, 1994.
278. 2, J. Biol. Chem., 269, 23250, 1994.
279. 2 is coupled to hormonally regulated release of arachidonic acid, Proc. Natl. Acad. Sci. U.S.A., 89, 6147, 1992.
280. 2 is phosphorylated and activated by MAP kinase, Cell, 72, 269, 1993.
281. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C, J. Biol. Chem., 268, 1960, 1993.
282. 2 enzymes studied by using a mammalian memmbrane as a substrate, Biochem. J., 301, 721, 1994.
283. 2 in a mixed vesicle model, J. Biol. Chem., 267, 18342, 1992.
284. 2 enzymes on product-containing vesicles: application to the determination of substrate preferences, Biochemistry, 32, 5949, 1993.
285. 2 during the hydrolysis of diacyl-and alkenylacylglycerophosphoethanolamine, Biochim. Biophys. Acta, 1212, 211, 1994.
286. 2, Anal. Biochem., 222, 110, 1994.
287. 2+ for membrane binding but not for catalytic activity, Biochem. Biophys. Res. Commun., 184, 118, 1992.
288. 2, Biochim. Biophys. Acta, 1167, 272, 1993.
289. 2 from rat kidney: divalent metal-dependent trapping of enzyme on product-containing vesicles, Biochemistry, 31, 3814, 1992.
290. 2 that exhibits lysophospholipase activity, J. Biol. Chem., 266, 11366, 1991.
291. 2, Eur. J. Biochem., 218, 629, 1993.
292. 2 and activation in mouse peritoneal macrophages, J. Biol. Chem., 270, 20439, 1995.
293. 2 gene, Nucl. Acids Res., 23, 293, 1995.
294. 2), Biochim. Biophys. Acta, 1217, 345, 1994.
295. 2 gene expression in rat mesangial cells is regulated posttranscriptionally, Biochem. J., 304, 417, 1994.
296. 2, EMBO J., 11, 4917, 1992.
297. 2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis, Proc. Natl. Acad. Sci. U.S.A., 90, 4475, 1993.
298. 2 gene in embryonic mouse cells, J. Biol. Chem., 269, 21786, 1994.
299. 2 activity and protein synthesis is blocked by dexamethasone in rat mesangial cells, FEBS Lett., 333, 339, 1993.
300. 2, J. Clin. Invest., 93, 571, 1994.
301. 2 by antisense and effects on endotoxin-induced
302. 2 and cyclooxygenase-2, Eur. J. Biochem., 226, 125, 1994.
303. 2 in glomerular mesangial cells, Biochem. J., 295, 763, 1993.
304. Onoe, Y., Miyaura, C., Kaminakayashiki, T., Nagai, Y., Noguchi, K., Chen, Q.-R., Seo, H., Ohta, H., Nozawa, S., Kudo, I., and Suda, T., IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts, J. Immunol., 156, 758, 1996.
305. 2 in rheumatoid synovial fibroblasts, Biochem. Biophys. Res. Commun., 184, 712, 1992.
306. 2 activity, Biochim. Biophys. Acta, 1127, 163, 1992.
307. 2 in human fibroblasts, J. Biol. Chem., 267, 23451, 1992.
308. 2 formation in rat mesangial cells, Eur. J. Biochem., 210, 169, 1992.
309. Galli, S. J., Zsebo, K. M., and Geissler, E. N., The kit ligand: stem cell factor, Adv. Immunol., 55, 1, 1994.
310. 2 generation in immature mouse mast cells, J. Biol. Chem., 270, 3239, 1995.
311. 4 synthase pathway in mouse mast cells, J. Biol. Chem., 270, 22653, 1995.
312. ε-receptor, J. Immunol., 153, 796, 1994.
313. 2 and prostaglandin endoperoxide synthase-2 and their roles in separate pathways of eicosanoid synthesis in mouse bone marrow-derived mast cells, Proc. Natl. Acad. Sci. U.S.A., 92, 6107, 1995.
314. 2 from cytosol to membranes in rat brain induced by calcium ions, Biochem. Biophys. Res. Commun., 170, 484, 1990.
315. 2 with membrane in the macrophage cell line RAW 264.7, J. Biol. Chem., 265, 5409, 1990.
316. 2 between the cytosol and the membrane fraction of rat liver macrophages, Eur. J. Biochem., 199, 355, 1991.
317. 2+-dependent membrane association, Biochem. J., 293, 255, 1993.
318. Bazzi, M. D. and Nelsestuen, G. L., Association of protein kinase C with phopsholipid vesicles, Biochemistry, 26, 115, 1987.
319. Brose, N., Petrenko, A. G., Sudhof, T. C., and Jahn, R., Synaptotagmin: a calcium sensor on the synaptic vesicle surface, Science, 256, 1021, 1992.
320. Igarashi, K., Kaneda, M., Yamaji, A., Saido, T. C., Kikkawa, U., Ono, Y., Inoue, K., and Umeda, M., A novel phosphatidylserine-binding peptide motif defined by an anti-idiotypic monoclonal antibody: localization of phosphatidylserine-specific binding sites on protein kinase C and phosphatidylserine decarboxylase, J. Biol. Chem., 270, 29075, 1995.
321. 2+/phospholipid binding, J. Biol. Chem., 268, 26386, 1993.
322. Chapman, E. R. and Jahn, R., Calcium-dependent interaction of the cytoplasmic region of synaptotagmin with membranes, J. Biol. Chem., 269, 5735, 1994.
323. Llinas, R., Sugimori, M., and Silver, R. B., Microdomains of high calcium concentration in a presynaptic terminal, Science, 256, 677, 1992.
324. 2 to the nuclear fraction upon macrophage activation, Biochem. Biophys. Res. Commun., 196, 147, 1993.
325. 2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen, J. Biol. Chem., 270, 15359, 1995.
326. 2 to the nuclear envelope and endoplasmic reticulum, J. Biol. Chem., 270, 30749, 1995.
327. Monta, I., Schindler, M., Regier, M. K., Otto, J. C., Hori, T., DeWitt, D. L., and Smith, W. L., Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2, J. Biol. Chem., 270, 10902, 1995.
328. Ohashi, K., Ruan, K.-H., Kulmacz, R. J., Wu, K. K., and Wang, L.-H., Primary structure of human thromboxane synthase determined from the cDNA sequence, J. Biol. Chem., 267, 789, 1992.
329. Kara, S., Miyata, A., Yokoyama, C., Inoue, H., Brugger, R., Lottspeich, F., Ullrich, V., and Tanabe, T., Isolation and molecular cloning of prostacyclin synthase from bovine endothelial cells, J. Biol. Chem., 269, 19897, 1994.
330. Malaviya, R., Malaviya, R., and Jakschik, B. A., Reversible translocation of 5-lipoxygenase in mast cells upon IgE/antigen stimulation, J. Biol. Chem., 268, 4939, 1993.
331. Woods, J. W., Evans, J. F., Ethier, D., Scott, S., Vickers, P. J., Hearn, L., Heibein, J. A., Charleson, S., and Singer, I. I., 5-Lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes, J. Exp. Med., 178, 1935, 1993.
332. 4, Proc. Natl. Acad. Sci. U.S.A., 91, 7663, 1994.
333. 2 activity, J. Biol. Chem., 265, 4934, 1990.
334. 2 activation, Biochem. J., 267, 461, 1990.
335. 2, Biochem. J., 287, 37, 1992.
336. Wijkander, J. and Sundler, R., A role for protein kinase C-mediated phosphorylation in the mobilization of arachidonic acid in mouse macrophages, Biochim. Biophys. Acta, 1010, 78, 1989.
337. Domin, J. and Rozengurt, E., Platelet-derived growth factor stimulates a biphasic mobilization of arachidonic acid in Swiss 3T3 cells, J. Biol. Chem., 268, 8927, 1993.
338. 2 phosphorylation and eicosanoid production by colony-stimulating factor-1, J. Biol. Chem., 269, 31693, 1994.
339. 2 in macrophages in response to bacteria, Eur. J. Biochem., 213, 81, 1993.
340. 2 activation by phosphorylation in mouse peritoneal macrophages, J. Biol. Chem., 268, 24506, 1993.
341. 2, J. Biol. Chem., 269, 19480, 1994.
342. 2 in human platelets, J. Biol. Chem., 268, 26796, 1993.
343. 2 independent of the mitogen-activated protein kinases ERK1/2, J. Biol. Chem., 270, 14816, 1995.
344. 2 pathway in a rat mast cell line: indications of different pathways for release of arachidonic acid and secretory granules, J. Immunol., 154, 5391,1995.
345. 2 and 5-lipoxygenase, J. Exp. Med., 182, 197, 1995.
346. 2 in human neutrophils, J. Biol. Chem., 270, 26543, 1995.
347. 2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells, J. Biol. Chem., 270, 2360, 1995.
348. 2 in vascular smooth-muscle cells, Biochem. J., 299, 197, 1994.
349. 2 activation in vivo requires phosphorylation followed by an increased intracellular calcium concentration, Biochem. J., 313, 91, 1996.
350. 2, J. Cell. Biochem. Suppl., 18D, 48, 1994.
351. Cobb, M. H. and Goldsmith, E. J., How MAP kinases are regulated, J. Biol. Chem., 270, 14843, 1995.
352. 2 expressed in insect cells and present in human monocytes, J. Biol. Chem., 271, 6987, 1996.
353. 2 by transforming growth factor-α in HEL-30 keratinocytes, J. Biol. Chem., 268, 16795, 1993.
354. 2 is required for the formation of interferon-stimulated gene factor three, EMBO J., 15, 1566, 1996.
355. 2 activity in isolated human platelet membranes, J. Biol. Chem., 264, 21466, 1989.
356. 2+ in HL-60 granulocytes, J. Biol. Chem., 267, 25966, 1992.
357. 2 activation, Arch. Biochem. Biophys., 261, 375, 1988.
358. 2 activity in bovine rod outer segments by the βγ subunits of transducin and its inhibition by the α subunit, Proc. Natl. Acad. Sci. U.S.A., 84, 3623, 1987.
359. + channel, Nature, 337, 555, 1989.
360. Bar-Sagi, D. and Feramisco, J. R., Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins, Science, 233, 1061, 1986.
361. Rhee, S. G. and Choi, K. D., Regulation of inositol phospholipid-specific phospholipase C isozymes, J. Biol. Chem., 267, 12393, 1992.
362. 2+ and mitogen-activated protein kinase regulation, J. Biol. Chem., 269, 1889, 1994.
363. Crespo, P., Xu, N., Simonds, W. F., and Gutkind, J. S., Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits, Nature, 369, 418, 1994.
364. Pumiglia, K. M., LeVine, H., Haske, T., Habib, T., Jove, R., and Decker, S. J., A direct interaction between G-protein βγ subunits and the raf-1 protein kinase, J. Biol. Chem., 270, 14251, 1995.
365. Druey, K. M., Blumer, K. J., Kang, V. H., and Kehrl, J. H., Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family, Nature, 379, 742, 1996.
366. 2, Biochemistry, 32, 5935, 1993.
367. 2 production in mast cells, J. Immunol., 155, 818, 1995.
368. 2 generation via prostaglandin endoperoxide synthase-2, J. Immunol., 155, 4445, 1995.
369. Park, D. J., Min, H. K., and Rhee, S. G., IgE-induced tyrosine phosphorylation of phospholipase C-γ1 in rat basophilic leukemia cells, J. Biol. Chem., 266, 24237, 1991.
370. Atkinson, T. P., Kaliner, M. A., and Hohman, R. J., Phospholipase C-γ1 is translocated to the membrane of rat basophilic leukemia cells in response to aggregation of IgE receptors, J. Immunol., 148, 2194, 1992.
371. εRI is not shared by a G protein-coupled receptor, J. Biol. Chem., 270, 10960, 1995.
372. Kulmacz, R. J. and Wang, L.-H., Comparison of hydroperoxide initiator requirement for the cyclooxygenase activities of prostaglandin H synthase-1 and -2, J. Biol. Chem., 270, 24019, 1995.
373. 4, J. Biol. Chem., 264, 19469, 1989.
374. 1 macrophages, J. Biol. Chem., 271, 6758, 1996.
375. Samet, J. M., Fasano, M. B., Fonteh, A. N., and Chilton, F. H., Selective induction of prostaglandin G/H synthase 1 by stem cell factor and dexamethasone in mast cells, J. Biol. Chem., 270, 8044, 1995.
376. Meade, E. A., Smith, W. L., and DeWitt, D. L., Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal antiinflammatory drugs, J. Biol. Chem., 268, 6610, 1993.
377. Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., and Vane, J. R., Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase, Proc. Natl. Acad. Sci. U.S.A., 90, 11693, 1994.
378. Peri, K. G., Hardy, P., Li, D. Y., Varma, D. R., and Chemtob, S., Prostaglandin G/H synthase-2 is a major contributor of brain prostaglandins in the newborn, J. Biol. Chem., 270, 24615, 1995.
379. Reddy, S. T. and Herschman, H. R., Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages, J. Biol. Chem., 269, 15473, 1994.
380. 2, J. Immunol., 155, 3570, 1995.
381. 2 is crucial in the cytotoxic action of tumor necrosis factor, J. Biol. Chem., 268, 11290, 1993.
382. 2 activity regulates the synthesis of platelet-activating factor in granulocytic HL-60 cells, J. Biol. Chem., 265, 12363, 1990.
383. Ramesha, C. S. and Pickett, W. C., Platelet-activating factor and leukotriene biosynthesis is inhibited in polymorphonuclear leukocytes depleted of arachidonic acid, J. Biol. Chem., 261, 7592, 1986.
384. 2 and acylation of lysophospholipids: the major regulators for platelet-activating factor production in rat neutrophils, J. Biochem. (Tokyo), 118, 442, 1995.
385. Nishizuka, Y., Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C, Science, 258, 607, 1992.
386. 2, J. Biol. Chem., 271, 6010, 1996.
387. 3, inhibits glucose-induced insulin secretion from isolated rat islets, Biochem. Biophys. Res. Commun., 218, 423, 1996.
388. 2 and the increased gene expression in the dentate gyms following transient forebrain ischemia, Mol. Brain Res., 25, 364, 1994.
389. 2 in rat tissue cytosol, Biochim. Biophys. Acta, 962, 345, 1988.
390. 2: a calcium-independent phospholipase with absolute sn-2 regiospecificity for diradyl glycerophospholipids, J. Biol. Chem., 265, 10622, 1990.
391. 2, J. Biol. Chem., 266, 14526, 1991.
392. 2: implications for the coordinated regulation of phospholipolysis and glycolysis, J. Biol. Chem., 268, 9892, 1993.
393. 2 isoform: fast atom bombardment mass spectroscopic and reverse-phase high-pressure liquid chromatography identification of choline and ethanolamine glycerophospholipid substrates, J. Clin. Invest., 91, 2513, 1993.
394. 2 is modulated by ATP: concordant ATP-induced alterations in enzyme kinetics and mechanism-based inhibition, Biochem. J., 280, 581, 1991.
395. 2 activities in canine vascular smooth muscle, Biochim. Bioiphys. Acta, 1165, 167, 1992.
396. 2 activity selective for hydrolysis of arachidonate which is stimulated by adenosine triphosphate and its specifically localized to islet β-cells, Biochemisty, 32, 327, 1993.
397. 2, J. Biol. Chem., 266, 7227, 1991.
398. 1 cells: isolation and characterization, J. Biol. Chem., 269, 9227, 1994.
399. 2 by bromoenol lactone and trifluoromethyl ketones, J. Biol. Chem., 270, 445, 1995.
400. 2 from bovine brain, Biochem. J., 299, 91, 1994.
401. 2 from bovine brain, Biochem. Biophys. Res. Commun., 199, 1158, 1994.
402. 2 and signal transduction, Brain Res. Rev., 21, 152, 1995.
403. 1 macrophages, Proc. Natl. Acad. Sci. U.S.A., 92, 8527, 1995.
404. 2, J. Biol. Chem., 268, 20713, 1993.
405. 2, J. Biol. Chem., 270, 14855, 1995.
406. 2 during rabbit myocardial ischemia which is highly selective for plasmalogen substrate, J. Biol. Chem., 266, 5629, 1991.
407. 2 in endocytosis, Proc. Natl. Acad. Sci. U.S.A., 90, 10255, 1993.
408. Lennartz, M. R. and Brown, E. J., Arachidonic acid is essential for IgG Fc receptor-mediated phagocytosis by human monocytes, J. Immunol., 147, 621, 1991.
409. Lennartz, M. R., Lefkowith, J. B., Bromley, F. A., and Brown, E. J., Immunoglobulin G-mediated phagocytosis activates a calcium-independent, phosphatidylethanolamine-specific phospholipase, J. Leukoc. Biol., 54, 389, 1993.
410. 2/lysophospholipase (phospholipase B) from guinea pig intestinal brush-border membrane, J. Biol. Chem., 264, 9470, 1989.
411. Gassama-Diagne, A., Rogalle, P., Fauvel, J., Willson, M., Klaébé, A., and Chap, H., Substrate specificity of phospholipase B from guinea pig intestine: a glycerol ester lipase with broad specificity, J. Biol. Chem., 267, 13418, 1992.
412. 2 and lysophospholipase activities (phospholipase B) with a stalked membrane protein, Lipids, 24, 357, 1989.
413. Boll, W., Schmid-Chanda, T., Semenza, G., and Mantel, N., Messenger RNAs expressed in intestine of adult but not baby rabbits: isolation of cognate cDNAs and characterization of a novel brush border protein with esterase and phospholipase activity, J. Biol. Chem., 268, 12901, 1993.
414. Hattori, M., Aral, H., and Inoue, K., Purification and characterization of bovine brain platelet-activating factor acetylhydrolase, J. Biol. Chem., 268, 18748, 1993.
415. Hattori, M., Adachi, H., Tsujimoto, M., Arai, H., and Inoue, K., Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase, Nature, 370, 216, 1994.
416. Hattori, M., Adachi, H., Tsujimoto, M., Arai, H., and Inoue, K., The catalytic subunit of bovine brain platelet-activating factor acetylhydrolase is a novel type of serine esterase, J. Biol. Chem., 269, 23150, 1994.
417. Hattori, M., Adachi, H., Aoki, J., Tsujimoto, M., Arai, H., and Inoue, K., Cloning and expression of a cDNA encoding the β-subunit (30-kDa subunit) of bovine brain platelet-activating factor acetylhydrolase, J. Biol. Chem., 270, 31345, 1995.
418. Neer, E. J., Schmidt, C. J., Nambudripad, R., and Smith, T. F., The ancient regulatory-protein family of WD-repeat proteins, Nature, 371, 297, 1994.
419. Wang, D.-S., Shaw, R., Hattori, M., Arai, H., Inoue, K., and Shaw, G., Binding of pleckstrin homology domains to WD40/β-transducin repeat containing segment of the protein product of the Lis-1 gene, Biochem. Biophys. Res. Commun., 209, 622, 1995.
420. Winkelmann, J. C., Costa, F. F., Linzie, B. L., and Forget, B. G., β spectrin in human skeletal muscle: tissue-specific differential processing of 3′ β spectrin pre-mRNA generates a β spectrin isoform with a unique carboxyl terminus, J. Biol. Chem., 265, 20449, 1990.
421. Honda, Z., Nakamura, M., Miki, I., Minami, M., Watanabe, T., Seyama, Y., Okado, H., Toh, H., Ito, K., Miyamoto, T., and Shimizu, T., Cloning by functional expression of platelet-activating factor receptor from guinea pig lung, Nature, 349, 342, 1991.
422. Izumi, T., Takano, T., Bito, H., Nakamura, M., Mutoh, H., Honda, Z., and Shimizu, T., Platelet-activating factor receptor, J. Lipid Med. Cell Sig., 12, 429, 1995.
423. Izumi, T. and Shimizu, T., Platelet-activating factor receptor: gene expression and signal transduction, Biochim. Biophys. Acta, 1259, 317, 1995.
424. Adachi, H., Tsujimoto, M., Hattori, M., Arai, H., and Inoue, K., cDNA cloning of human cytosolic platelet-activating factor acetylhydrolase γ-subunit and its mRNA expression in human tissues, Biochem. Biophys. Res. Commun., 214, 180, 1995.
425. Hattori, K., Hattori, M., Adachi, H., Tsujimoto, M., Arai, H., and Inoue, K., Purification and characterization of platelet-activating factor acetylhydrolase II from bovine liver cytosol, J. Biol. Chem., 270, 22308, 1995.
426. Stafforini, D. M., Rollins, E. N., Prescott, S. M., and McIntyre, T. M., The platelet-activating factor acetylhydrolase from human erythrocytes: purification and properties, J. Biol. Chem., 268, 3857, 1993.
427. Tjoelker, L. W., Wilder, C., Eberhardt, C., Stafforini, D.M., Dietsch, G., Schimpf, B., Hooper, S., Trong, H. L., Cousens, L. S., Zimmerman, G. A., Yamada, Y., McIntyre, T. M., Prescott, S. M., and Gray, P. W., Antiinflammatory properties of a platelet-activating factor acetylhydrolase, Nature, 374, 549, 1995.
428. Stafforini, D. M., McIntyre, T. M., Carter, M. E., and Prescott, S. M., Human plasma platelet-activating factor acetylhydrolase: association with lipoprotein partides and role in the degradation of platelet-activating factor, J. Biol. Chem., 262, 4215, 1987.
429. 2 with a catalytic triad, J. Biol. Chem., 270, 25481, 1995.
430. Zupan, L. A., Steffens, D. L., Berry, C. A., Landt, M., and Gross, R. W., Cloning and expression of a human 14-3-3 protein mediating phospholipolysis: identification of an arachidonoyl-enzyme intermediate during catalysis, J. Biol. Chem., 267, 8707, 1992.
431. 2 isoforms: activation by physiologic concentrations of calcium ion, J. Biol. Chem., 261, 10467, 1986.
432. Aitken, A., 14-3-3 proteins on the MAP, Trends Biochem. Sci., 20, 95, 1995.
433. 2 (14-3-3 protein) with the platelet glycoprotein Ib-IX complex, J. Biol. Chem., 269, 18287, 1994.
434. 2 activity, Biochem. J., 299, 853, 1994.
435. 2+ dependence and localization, Biochim. Biophys. Acta, 550, 450, 1979.
436. 2 in intact membranes of sheep erythrocytes, J. Biochem. (Tokyo), 94, 841, 1983.
437. 2 levels in murine mast cells by recombinant stem cell factor, J. Clin. Invest., 96, 1432, 1995.
438. 2 by phosphorylation in rat mesangial cells, J. Clin. Invest., 93, 1224, 1994.
439. 2+ and phosphorylation, Biochem. J., 311, 189, 1995.